Monica Bertagnolli - Sep 8, 2021 Form 4 Insider Report for LEAP THERAPEUTICS, INC. (LPTX)

Role
Director
Signature
/s/ Douglas E. Onsi, as Attorney-in-Fact for Monica Bertagnolli
Stock symbol
LPTX
Transactions as of
Sep 8, 2021
Transactions value $
$0
Form type
4
Date filed
9/10/2021, 09:01 PM
Previous filing
Jun 2, 2021
Next filing
Nov 19, 2021

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction LPTX Stock Option (Right to Buy) Award $0 +65K $0.00 65K Sep 8, 2021 Common Stock 65K $1.58 Direct F1
transaction LPTX Stock Option (Right to Buy) Award $0 +16.2K $0.00 16.2K Sep 8, 2021 Common Stock 16.2K $1.58 Direct F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The Option was granted pursuant to Leap's 2016 Equity Incentive Plan and shall vest and become exercisable in a series of 12 equal quarterly installments until the Option is fully vested, with the first such quarterly installment vesting on the three-month anniversary of September 8, 2021, the Vesting Start Date.
F2 The Option was granted pursuant to Leap's 2016 Equity Incentive Plan and shall vest and become exercisable with respect to 50% of the Option on September 30, 2021, and with respect to the remaining 50% of the Option on December 31, 2021.